Stay in the Know
J Virol: Scientists Reveal the Molecular Mechanism of Human T Cell Leukemia Virus Infection and Spread
January 8, 2019
Recently, a research report published in the international journal Journal of Virology , scientists from the University of Minnesota developed a new strategy through research, or hopefully blocked A highly contagious virus spreads in remote parts of central Australia. Learn more.
Research Brief: Pathway for human cancer virus creation discovered
September 24, 2018
Finding out where a virus replicates inside the body is key to understanding how to stop an infection from spreading. In the case of the first human cancer virus discovered—human T-cell leukemia virus type 1 (HTLV-1)—researchers at the University of Minnesota’s Institute for Molecular Virology (IMV) have discovered a novel pathway for how this distant cousin of the human immunodeficiency virus (HIV) is created from cells. Learn more.
Research Brief: UMN researchers make key discovery about human cancer virus protein
May 14, 2018
University of Minnesota researchers in the Institute for Molecular Virology (IMV) have made a key discovery that could have important implications for developing a strategy to stop the spread of a highly infectious virus currently spreading among remote areas of central Australia. Called human T-cell leukemia virus type 1 (HTLV-1), infection rates are reportedly exceeding 40 percent among adults in those communities. HTLV-1, the first human cancer virus discovered, can cause leukemia and lymphoma. Learn more.
An emotional call to eradicate ancient cousin of HIV
May 10, 2018
In an open letter, experts and advocates call for public health efforts to eradicate HTLV-1. Learn more.
Distinct differences in structure, features of retroviruses
July 5, 2016
In the most comprehensive study of its kind, researchers report that most types of retroviruses have distinct, non-identical virus structures. Learn more.
U of M researchers discover cancer drugs can treat HIV
September 11, 2010
University of Minnesota researchers are being commended for a big research discovery in HIV/AIDS research. Professor Louis Mansky and his research team have found that two cancer drugs, decitabine and gemicitabine, can essentially force HIV to mutate at a much higher rate and to kill itself off. Learn more.
Cancer drugs to defeat HIV?
August 23, 2010
U researchers found the mixture caused the AIDS virus to self-destruct in lab tests. Scientists hope it speeds up the discovery of new treatments. Learn more.
Cancer Drugs Force HIV to Mutate to Death
August 23, 2010
HIV, the AIDS virus, has the ability to change quickly, frustrating efforts to find a vaccine. However, the apparent advantage of mutation may also be a weakness. Learn more.
Ancient HTLV-1 virus affecting millions to receive 'rapid action', Health Minister Greg Hunt signals
May 24, 2018
A major new taskforce will focus on Australia's response to the blood-borne virus HTLV-1, found in Aboriginal communities at 1,000 times the rate of anywhere else in the world. Learn more.
Scientists accelerate virus evolution to exterminate it
January 16, 2010
Many of the mutations that hit the virus are fatal. Effects of 'lethal mutagenesis', but are still unknown. Learn more.
Using a Virus’s Knack for Mutating to Wipe It Out
January 4, 2010
Evolution is a virus’s secret weapon. The virus can rapidly slip on new disguises to evade our immune systems, and it can become resistant to antiviral drugs. But some scientists are turning the virus’s secret weapon against it. Learn more.